Crosstalk between long noncoding RNA and microRNA in Cancer.
Angiogenesis
Cancer
Epithelial-mesenchymal transition
Long-noncoding RNA
Metastasis
MicroRNA
Neovascularization
Vascular mimicry
Journal
Cellular oncology (Dordrecht)
ISSN: 2211-3436
Titre abrégé: Cell Oncol (Dordr)
Pays: Netherlands
ID NLM: 101552938
Informations de publication
Date de publication:
Aug 2023
Aug 2023
Historique:
accepted:
26
03
2023
medline:
21
7
2023
pubmed:
28
5
2023
entrez:
28
5
2023
Statut:
ppublish
Résumé
miRNAs and lncRNAs play a central role in cancer-associated gene regulations. The dysregulated expression of lncRNAs has been reported as a hallmark of cancer progression, acting as an independent prediction marker for an individual cancer patient. The interplay of miRNA and lncRNA decides the variation of tumorigenesis that could be mediated by acting as sponges for endogenous RNAs, regulating miRNA decay, mediating intra-chromosomal interactions, and modulating epigenetic components. This paper focuses on the influence of crosstalk between lncRNA and miRNA on cancer hallmarks such as epithelial-mesenchymal transition, hijacking cell death, metastasis, and invasion. Other cellular roles of crosstalks, such as neovascularization, vascular mimicry, and angiogenesis were also discussed. Additionally, we reviewed crosstalk mechanism with specific host immune responses and targeting interplay (between lncRNA and miRNA) in cancer diagnosis and management.
Identifiants
pubmed: 37245177
doi: 10.1007/s13402-023-00806-9
pii: 10.1007/s13402-023-00806-9
pmc: PMC10356678
doi:
Substances chimiques
MicroRNAs
0
RNA, Long Noncoding
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
885-908Informations de copyright
© 2023. The Author(s).
Références
Cells. 2020 Mar 05;9(3):
pubmed: 32151082
Biochem Biophys Res Commun. 2018 Oct 12;504(4):629-634
pubmed: 30193732
Cell Physiol Biochem. 2018;51(3):1149-1163
pubmed: 30481751
Eur Rev Med Pharmacol Sci. 2018 Apr;22(8):2233-2245
pubmed: 29762824
J Exp Clin Cancer Res. 2015 Oct 09;34:116
pubmed: 26452542
Nat Med. 2017 Nov;23(11):1331-1341
pubmed: 29035371
Eur J Cell Biol. 2018 Jun;97(5):369-378
pubmed: 29773344
J Biol Chem. 2010 Feb 5;285(6):3554-3560
pubmed: 20008322
Mol Cancer Res. 2012 Sep;10(9):1135-46
pubmed: 22826464
Tumour Biol. 2017 Jul;39(7):1010428317690998
pubmed: 28675122
Med Res Rev. 2017 Nov;37(6):1231-1274
pubmed: 28643862
J Hematol Oncol. 2018 Jul 3;11(1):89
pubmed: 29970122
Oncogene. 2017 Jan 19;36(3):318-331
pubmed: 27345398
J Biol Chem. 2015 Jan 9;290(2):926-40
pubmed: 25391651
Oncotarget. 2015 Sep 8;6(26):22513-25
pubmed: 26068968
Nucleic Acids Res. 2016 Jul 8;44(W1):W176-80
pubmed: 27198221
Crit Rev Clin Lab Sci. 2002 Nov;39(6):527-79
pubmed: 12484499
J Cell Physiol. 2018 Jan;234(1):757-768
pubmed: 30078184
Biochim Biophys Acta Mol Basis Dis. 2018 Sep;1864(9 Pt B):2871-2880
pubmed: 29807108
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Biochem Biophys Res Commun. 2018 Dec 9;507(1-4):260-266
pubmed: 30442366
Oncotarget. 2014 Apr 30;5(8):2276-92
pubmed: 24810364
Front Oncol. 2022 Sep 13;12:977933
pubmed: 36176419
Oncogene. 2018 Jul;37(28):3822-3838
pubmed: 29643475
Cold Spring Harb Perspect Biol. 2011 Aug 01;3(8):a005090
pubmed: 21807843
Biomed Pharmacother. 2019 Jan;109:1851-1859
pubmed: 30551440
Nat Rev Cancer. 2003 May;3(5):362-74
pubmed: 12724734
Mol Cancer. 2010 May 17;9:108
pubmed: 20478051
Cell Death Dis. 2019 Feb 18;10(3):168
pubmed: 30778047
Stem Cells. 2018 Dec;36(12):1863-1874
pubmed: 30171660
Oncotarget. 2017 Mar 14;8(11):18260-18270
pubmed: 28209917
Mol Ther Nucleic Acids. 2017 Sep 15;8:356-369
pubmed: 28918035
Biochim Biophys Acta. 2016 Jan;1859(1):169-76
pubmed: 26149773
Int J Mol Sci. 2015 Jan 28;16(2):2942-55
pubmed: 25636036
Cancer Med. 2017 Dec;6(12):2897-2908
pubmed: 29125238
Mol Ther Nucleic Acids. 2018 Mar 2;10:170-186
pubmed: 29499931
Biomed Res Int. 2014;2014:345605
pubmed: 25045664
PLoS One. 2018 Oct 5;13(10):e0198231
pubmed: 30289954
Oncotarget. 2015 Apr 10;6(10):7899-917
pubmed: 25760077
Nat Rev Genet. 2009 Mar;10(3):155-9
pubmed: 19188922
Biofactors. 2020 May;46(3):487-496
pubmed: 31889362
Cancer Res. 2014 Dec 1;74(23):6890-902
pubmed: 25277524
Horm Res. 1992;38 Suppl 1:56-62
pubmed: 1295814
Curr Cancer Drug Targets. 2012 Jul;12(6):716-40
pubmed: 22515522
Biomed Pharmacother. 2023 Mar;159:114269
pubmed: 36682246
Cell Physiol Biochem. 2018;46(3):1275-1285
pubmed: 29680837
Biochim Biophys Acta. 2016 Jun;1859(6):792-804
pubmed: 26877236
Cancer Cell Int. 2019 Nov 27;19:313
pubmed: 31787850
Nature. 2016 Jan 21;529(7586):298-306
pubmed: 26791720
Nature. 2019 Mar;567(7747):181-182
pubmed: 30850740
Mol Med Rep. 2019 Feb;19(2):1248-1255
pubmed: 30535431
J Anim Sci Technol. 2018 Oct 25;60:25
pubmed: 30386629
Genome Res. 2012 May;22(5):885-98
pubmed: 22406755
J Clin Invest. 2013 Apr;123(4):1542-55
pubmed: 23454749
Semin Cell Dev Biol. 2014 Oct;34:9-14
pubmed: 24965208
Cancer Cell. 2007 Sep;12(3):215-29
pubmed: 17785203
FEBS J. 2013 Sep;280(18):4531-8
pubmed: 23815091
J Mol Histol. 2004 Mar;35(3):211-31
pubmed: 15339042
Biochem Biophys Res Commun. 2017 Aug 5;489(4):404-412
pubmed: 28564590
Int J Clin Exp Pathol. 2018 Aug 01;11(8):3943-3951
pubmed: 31949782
Biomed Pharmacother. 2017 Dec;96:884-891
pubmed: 29145165
Int J Cancer. 2013 Jul 15;133(2):267-74
pubmed: 23001607
Nat Biotechnol. 2013 Sep;31(9):827-32
pubmed: 23873081
Jpn J Clin Oncol. 2015 Nov;45(11):1055-63
pubmed: 26373319
Braz J Med Biol Res. 2020 Jan 13;53(1):e8883
pubmed: 31939597
Mol Med Rep. 2018 Sep;18(3):3068-3076
pubmed: 30015867
Curr Biol. 2014 Aug 18;24(16):R762-76
pubmed: 25137592
Front Med (Lausanne). 2020 Nov 30;7:612393
pubmed: 33330574
Endocr Rev. 2015 Feb;36(1):25-64
pubmed: 25426780
Carcinogenesis. 2013 Mar;34(3):577-86
pubmed: 23222811
Mol Med Rep. 2016 Feb;13(2):1463-9
pubmed: 26708950
Cell Physiol Biochem. 2017;43(6):2548-2561
pubmed: 29130995
Cell. 2011 Nov 23;147(5):992-1009
pubmed: 22118458
Cell Death Differ. 2013 Nov;20(11):1558-68
pubmed: 23933812
Dig Dis Sci. 2018 Apr;63(4):890-899
pubmed: 29427222
Mol Med Rep. 2018 Sep;18(3):3059-3067
pubmed: 30015945
Onco Targets Ther. 2018 Oct 18;11:7197-7204
pubmed: 30425512
Comput Struct Biotechnol J. 2021 Apr 27;19:2567-2574
pubmed: 34025943
Cancer Lett. 2020 Nov 1;492:71-83
pubmed: 32860852
Oncol Res. 2018 Dec 27;27(1):55-64
pubmed: 29523218
Mol Cell Biochem. 2017 Jul;431(1-2):45-54
pubmed: 28364379
Elife. 2016 Apr 14;5:
pubmed: 27077950
Nat Rev Cancer. 2018 Feb;18(2):128-134
pubmed: 29326430
Cell Cycle. 2019 Dec;18(23):3288-3299
pubmed: 31615303
Nat Biotechnol. 2011 Jul 31;29(8):742-9
pubmed: 21804560
Cell Death Dis. 2020 Sep 19;11(9):780
pubmed: 32951010
N Engl J Med. 2005 Oct 27;353(17):1793-801
pubmed: 16251535
Lab Invest. 1984 Dec;51(6):624-34
pubmed: 6209468
Nature. 2010 Apr 15;464(7291):1071-6
pubmed: 20393566
Cell Physiol Biochem. 2018;46(1):401-417
pubmed: 29590659
Gene. 2018 Nov 15;676:298-305
pubmed: 30144501
Cell Physiol Biochem. 2018;45(1):131-147
pubmed: 29310118
Br J Cancer. 2015 Mar 17;112(6):957-62
pubmed: 25742467
Eur Rev Med Pharmacol Sci. 2019 May;23(9):3742-3748
pubmed: 31115000
Oncotarget. 2017 Jan 3;8(1):644-657
pubmed: 27893417
Am J Pathol. 1999 Sep;155(3):739-52
pubmed: 10487832
Crit Rev Oncol Hematol. 2022 Sep;177:103753
pubmed: 35803452
Crit Rev Oncol Hematol. 2022 Jun;174:103675
pubmed: 35381343
Oncotarget. 2016 Mar 22;7(12):13479-90
pubmed: 26872371
Cancer Cell Int. 2018 Sep 18;18:143
pubmed: 30250401
Theranostics. 2017 Oct 17;7(19):4836-4849
pubmed: 29187907
ScientificWorldJournal. 2014 Feb 02;2014:896206
pubmed: 24672386
J Clin Invest. 2014 Dec;124(12):5109-28
pubmed: 25401471
Onco Targets Ther. 2019 May 22;12:3945-3954
pubmed: 31190891
Biochem Biophys Res Commun. 2014 Jun 6;448(3):315-22
pubmed: 24388988
Blood. 2008 Nov 15;112(10):4202-12
pubmed: 18713946
Cell Prolif. 2020 Jul;53(7):e12823
pubmed: 32515533
Exp Cell Res. 2018 Jul 15;368(2):194-201
pubmed: 29723509
Oncol Lett. 2017 Apr;13(4):2442-2448
pubmed: 28454417
Stem Cells. 2011 Jun;29(6):888-94
pubmed: 21557392
Clin Exp Pharmacol Physiol. 2020 May;47(5):877-885
pubmed: 31953866
Nat Rev Cancer. 2011 Feb;11(2):85-95
pubmed: 21258394
Tumour Biol. 2016 Feb;37(2):1683-91
pubmed: 26311052
Oncol Lett. 2017 Nov;14(5):5556-5562
pubmed: 29113184
Int J Mol Sci. 2018 Sep 11;19(9):
pubmed: 30208633
Cell. 2011 Aug 5;146(3):353-8
pubmed: 21802130
Int J Mol Sci. 2017 Jun 02;18(6):
pubmed: 28574440
Methods Mol Biol. 2016;1402:271-286
pubmed: 26721498
Oncotarget. 2014 Apr 30;5(8):2318-29
pubmed: 24810858
Cancer Cell. 2012 Dec 11;22(6):725-36
pubmed: 23201165
Cancer Lett. 2016 Oct 28;381(2):359-69
pubmed: 27543358
Cancer Lett. 2016 Nov 1;382(1):64-76
pubmed: 27591936
Cell Death Dis. 2018 Nov 21;9(12):1158
pubmed: 30464170
Cell Cycle. 2017;16(22):2212-2219
pubmed: 28881158
Front Oncol. 2019 Jul 25;9:669
pubmed: 31404273
Oncol Lett. 2020 Jan;19(1):595-605
pubmed: 31897175
J Exp Clin Cancer Res. 2015 Feb 19;34:18
pubmed: 25884472
Cell. 2005 Jan 14;120(1):15-20
pubmed: 15652477
J Cell Biochem. 2019 May;120(5):6926-6936
pubmed: 30652355
Gastric Cancer. 2020 Mar;23(2):212-227
pubmed: 31463827
Curr Opin Genet Dev. 2011 Apr;21(2):194-8
pubmed: 21330130
Nat Cell Biol. 2012 Jun 10;14(7):659-65
pubmed: 22684254
J Cell Physiol. 2018 Nov;233(11):8630-8638
pubmed: 29797562
Oncotarget. 2016 Jun 14;7(24):36743-36754
pubmed: 27167339
Dev Cell. 2013 Apr 15;25(1):69-80
pubmed: 23541921
Breast Cancer Res. 2020 Mar 6;22(1):26
pubmed: 32143670
Breast Cancer Res. 2018 Apr 18;20(1):32
pubmed: 29669595
BMC Genomics. 2007 Jun 07;8:152
pubmed: 17555584
Tumour Biol. 2017 Mar;39(3):1010428317694326
pubmed: 28351322
Biomed Pharmacother. 2022 Jul;151:113122
pubmed: 35594718
Clin Transl Oncol. 2016 Jul;18(7):660-5
pubmed: 26680632
Arch Biochem Biophys. 2017 Jun 1;623-624:1-8
pubmed: 28137422
Int J Biol Sci. 2020 Jan 1;16(1):1-11
pubmed: 31892841
Arch Biochem Biophys. 2016 Nov 15;610:1-7
pubmed: 27693036
J Cell Biochem. 2019 Aug;120(8):12290-12299
pubmed: 30805988
Int J Gynecol Cancer. 2017 Jul;27(6):1096-1108
pubmed: 28472815
Can J Physiol Pharmacol. 2018 Sep;96(9):909-915
pubmed: 29883549
Tumour Biol. 2016 Nov;37(11):14733-14743
pubmed: 27629141
Biomed Pharmacother. 2022 Sep;153:113345
pubmed: 35810692
Tumour Biol. 2016 Jun;37(6):7383-94
pubmed: 26676637
Brief Funct Genomics. 2016 May;15(3):257-65
pubmed: 26685282
Oncotarget. 2017 May 30;8(22):36410-36422
pubmed: 28430582
Oncol Res. 2018 May 7;26(4):537-546
pubmed: 28762326
Cell Death Dis. 2016 Jun 30;7(6):e2278
pubmed: 27362796
FEBS Open Bio. 2018 Oct 18;8(11):1855-1865
pubmed: 30410864
Cancer Manag Res. 2019 May 07;11:4209-4221
pubmed: 31118816
Genes Dev. 2009 Jul 1;23(13):1494-504
pubmed: 19571179
Oncol Res. 2017 Nov 2;25(9):1529-1541
pubmed: 28315290
Cancer Biol Ther. 2020;21(1):17-25
pubmed: 31591939
Nat Rev Cancer. 2003 Jun;3(6):401-10
pubmed: 12778130
Onco Targets Ther. 2018 May 01;11:2475-2487
pubmed: 29760557
Tumour Biol. 2015 May;36(5):3129-36
pubmed: 25809705
Int J Mol Sci. 2012 Dec 27;14(1):480-95
pubmed: 23271365
Arch Iran Med. 2016 Jul;19(7):508-17
pubmed: 27362246
Mol Cancer. 2014 Apr 28;13:92
pubmed: 24775712
Mod Pathol. 2015 Jan;28(1):4-13
pubmed: 24925053
Brief Funct Genomics. 2016 May;15(3):200-21
pubmed: 26685283
BMC Cancer. 2012 Dec 07;12:583
pubmed: 23217186
Biosci Rep. 2019 May 2;39(5):
pubmed: 30940776
Exp Ther Med. 2019 Jun;17(6):4715-4722
pubmed: 31105791
Cell. 2006 Nov 17;127(4):679-95
pubmed: 17110329
Cell Death Discov. 2021 Feb 8;7(1):30
pubmed: 33558499
Cancer Sci. 2018 Oct;109(10):3197-3208
pubmed: 30022558
Biomed Pharmacother. 2018 Oct;106:1607-1615
pubmed: 30119236
Respir Res. 2015 Jun 18;16:72
pubmed: 26081431
Mol Cancer. 2019 Mar 13;18(1):40
pubmed: 30866952
PLoS One. 2013;8(2):e53823
pubmed: 23405074
Cancer Res. 2020 Feb 15;80(4):922
pubmed: 32060228
Med Oncol. 2016 Aug;33(8):88
pubmed: 27389544
Brief Bioinform. 2020 Mar 23;21(2):441-457
pubmed: 30715152
Mol Cancer. 2011 Apr 13;10:38
pubmed: 21489289
Sci Rep. 2016 Apr 05;6:23892
pubmed: 27046651